ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 995

Use of Opiate Diminished the Treatment Benefits of Motivational Interviewing for Fibromyalgia

Dennis Ang1 and James Slaven2, 1Wake Forest University, Winston-Salem, NC, 2Biostatistics, Indiana University, Indianapolis, IN

Meeting: 2016 ACR/ARHP Annual Meeting

Date of first publication: September 28, 2016

Keywords: opioids

  • Tweet
  • Email
  • Print
Session Information

Date: Sunday, November 13, 2016

Title: Fibromyalgia, Soft Tissue Disorders, Regional and Specific Clinical Pain Syndromes

Session Type: ACR Concurrent Abstract Session

Session Time: 4:30PM-6:00PM

Background/Purpose: Opiate is not indicated in the treatment of fibromyalgia (FM). In fact, chronic use of opiate may even worsen the symptoms of fibromyalgia. There are reports in other pain conditions that long term use of opiate may even contribute to pain chronicity or the persistence of pain. Given the known medical complications from opiate (e.g., cognitive dysfunction) we hypothesized that the use of opiate may modify (or diminish) the effects of motivational interviewing (MI) treatment intervention on FM-relevant clinical outcomes.

Methods: This is a secondary data analysis of a 36-week randomized clinical trial to assess the efficacy of MI to promote physical activity among patients with FM. Participants were randomized to 1 of 2 treatment arms: 6 phone-based MI sessions (n=107) or an equal number of FM self-management instructions (attention control/AC, n=109). Subjects were evaluated at 4 time points: baseline, week 12 (post-intervention), week 24 and week 36. In the previous main outcome analyses†, MI was marginally superior (p=0.06) to AC in improving global FM symptom severity (as measured by Fibromyalgia Impact Questionnaire/FIQ total) from baseline to week 36. For the current analyses, the clinical outcomes were changes in FIQ total and SF36 physical function scores, from baseline to each follow-up visit. At study entry, subjects were categorized as opiate users vs. non-users.  Repeated measures ANOVA were used to assess treatment effects within each category.

Results: Approximately 5 subjects in MI and 8 subjects in the AC group had missing data; and therefore, were not included in the analyses.

 

MI

AC

p-value

Improvement in global FM severity (FIQ total)

 

 

 
     Opiate users

-9.90 (1.78), n=35

-9.21 (1.73), n=35

0.781
     Opiate non-users

-15.42 (1.23), n=66

-11.90 (1.20), n=66

0.042*
 

 

 

 
Improvement in SF36 physical function

 

 

 
     Opiate users

9.84 (2.00), n=35

7.38 (1.93), n=35

0.375
     Opiate non-users

14.04 (1.35), n=67

10.08 (1.33), n=66

0.037*

Values are means (standard errors) Stratifying the data based on the use of anticonvulsant (i.e., pregabalin or gabapentin) at study entry, we found the reverse (data not shown).  Specifically, treatment benefits from MI were observed among anticonvulsant users, but not among non-users.

Conclusion: In contrast to opiate users, opiate non-users reported greater treatment benefits from MI. Based on our findings, a hypothesis can be made that opiate interferes with the (biological and/or psychological) mechanisms of psychoeducational treatment intervention for FM.  If replicated in future studies, opiate status may guide clinician on when best to offer MI for patients with FM. †Ang DC et al. Research to Encourage Exercise for Fibromyalgia. Clin J Pain 2013; 29:296-304


Disclosure: D. Ang, None; J. Slaven, None.

To cite this abstract in AMA style:

Ang D, Slaven J. Use of Opiate Diminished the Treatment Benefits of Motivational Interviewing for Fibromyalgia [abstract]. Arthritis Rheumatol. 2016; 68 (suppl 10). https://acrabstracts.org/abstract/use-of-opiate-diminished-the-treatment-benefits-of-motivational-interviewing-for-fibromyalgia/. Accessed .
  • Tweet
  • Email
  • Print

« Back to 2016 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/use-of-opiate-diminished-the-treatment-benefits-of-motivational-interviewing-for-fibromyalgia/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology